Sintx Technologies (SINT) Retained Earnings (2013 - 2026)
Sintx Technologies' (SINT) quarterly Retained Earnings came in at $295.9 million in Q1 2026, up 1.34% year-on-year from $292.0 million in Q1 2025, and little changed quarter-over-quarter from $295.1 million in Q4 2025.
Sintx Technologies (SINT) Retained Earnings (2013 - 2026) Analysis & Trends
Sintx Technologies' Retained Earnings history runs 14 years deep, the most recent figure standing at $295.9 million for Q1 2026.
- On a quarterly basis, Retained Earnings rose 1.34% year-over-year to $295.9 million in Q1 2026; TTM through Mar 2026 was $295.9 million, a 1.34% increase from a year earlier, with the FY2025 full-year figure at $295.1 million, up 3.33% from the prior year.
- Retained Earnings held at $295.9 million in Q1 2026 per SINT's latest filing, from $295.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at $295.9 million in Q1 2026 and bottomed at -$289.9 million in Q3 2025.
- The 5-year median for Retained Earnings is $267.5 million (2022), against an average of $21.2 million.
- Across the five-year window, Retained Earnings soared 209.73% in 2022 and sank 201.5% in 2025, its largest moves.
- Year by year, Retained Earnings stood at $268.2 million in 2022, then slumped by 200.95% to -$270.7 million in 2023, then surged by 205.51% to $285.6 million in 2024, then increased by 3.33% to $295.1 million in 2025, then climbed by 0.27% to $295.9 million in 2026.
- Per Business Quant, the three latest SINT Retained Earnings figures stand at $295.9 million (Q1 2026), $295.1 million (Q4 2025), and -$289.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | Sintx Technologies | 17,274.80 | -1.87 Mn | 144,000.00 | 295.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 295.92 Mn |
| Dec 31, 2025 | 295.12 Mn |
| Sep 30, 2025 | -289.89 Mn |
| Jun 30, 2025 | -286.00 Mn |
| Mar 31, 2025 | 292.00 Mn |
| Dec 31, 2024 | 285.62 Mn |
| Sep 30, 2024 | 285.61 Mn |
| Jun 30, 2024 | -273.80 Mn |
| Mar 31, 2024 | -271.60 Mn |
| Dec 31, 2023 | -270.70 Mn |
| Sep 30, 2023 | 279.04 Mn |
| Jun 30, 2023 | -265.20 Mn |
| Mar 31, 2023 | -262.75 Mn |
| Dec 31, 2022 | 268.15 Mn |
| Sep 30, 2022 | 267.67 Mn |
| Jun 30, 2022 | -255.80 Mn |
| Mar 31, 2022 | 267.47 Mn |
| Dec 31, 2021 | -250.42 Mn |
| Sep 30, 2021 | -248.28 Mn |
| Jun 30, 2021 | 267.17 Mn |